Period Ending | Dec 31, 2010 | Dec 31, 2009 | Dec 31, 2008 |
---|
Total Revenue
|
1,936,000
|
1,709,000
|
1,762,000
| Cost of Revenue | 848,000 | 771,000 | 813,000 | |
Gross Profit
|
1,088,000
|
938,000
|
949,000
| |
|
Operating Expenses |
|
Research Development | 147,000 | 117,000 | 108,000 |
|
Selling General and Administrative | 526,000 | 483,000 | 508,000 |
|
Non Recurring |
-
|
-
|
-
|
|
Others |
-
|
-
|
-
|
|
|
|
Total Operating Expenses |
-
|
-
|
-
| | |
Operating Income or Loss
|
415,000
|
338,000
|
333,000
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net | (1,000) | (4,000) | 5,000 |
|
Earnings Before Interest And Taxes | 414,000 | 334,000 | 338,000 |
|
Interest Expense |
-
|
-
|
-
|
|
Income Before Tax | 414,000 | 334,000 | 338,000 |
|
Income Tax Expense | 113,000 | 80,000 | 88,000 |
|
Minority Interest |
-
|
-
|
-
|
|
|
|
Net Income From Continuing Ops | 301,000 | 254,000 | 250,000 | |
|
Non-recurring Events |
|
Discontinued Operations |
-
|
-
|
-
|
|
Extraordinary Items |
-
|
-
|
-
|
|
Effect Of Accounting Changes |
-
|
-
|
-
|
|
Other Items |
-
|
-
|
-
| | |
Net Income
|
301,000
|
254,000
|
250,000
| Preferred Stock And Other Adjustments |
-
|
-
|
-
| |
Net Income Applicable To Common Shares
|
301,000
|
254,000
|
250,000
|
|